Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-1027

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-1027 Category Tag

Product Details

Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Torapsel is a 42-89-glycoprotein (human clone PMT21:PL85 P-selectin glycoprotein ligand 1) fused with immunoglobulin (human constant region). It has been used for the prevention of Ischemia Reperfusion Injury

Products Name (INN Index)

Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL

INN Name

torapsel

Target

SELP

Format

Fusion Protein

Derivation

Human

Species Reactivity

Human

CH1 Isotype

Fusion – [SELPLG (selectin P ligand, selectin P glycoprotein ligand, PSGL-1, CD162) 42-89]2 – IGHG1 Fc (Fragment constant)

VD LC

Fusion – [SELPLG (selectin P ligand, selectin P glycoprotein ligand, PSGL-1, CD162) 42-89]2 – IGHG1 Fc (Fragment constant)

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Wyeth Pharmaceuticals (Madison NJ USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

SELP

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide